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Murine S100A8 (A8) is a major cytoplasmic neutrophil protein and is converted to novel
oxidation products containing Cys– amino–Lys sulfinamide cross-links and Met–sulfoxide by
the neutrophil oxidant HOCl. Seven products were separated using RP-HPLC, with electros-
pray ionization mass spectrometry (ESI-MS) masses after deconvolution of 10,354, 10,388, 1,
and 20,707, 3 Da, and all were resistant to reduction by dithiothreitol. The major products
with masses of 10,354 Da contained Cys41–Lys34/35 intramolecular cross-links. Additional
isomeric products with identical masses (10,354 Da) were isolated and peptide mapping and
ESI/MS indicated that Cys41 forms covalent sulfinamide cross-links with either Lys6, Lys76,
Lys83, or Lys87 present in A8. Electrospray low energy collisionally induced (CID) spectra of
multiply-charged AspN digest peptides with sulfinamide cross-links contained characteristic
fragmentations that corresponded to simple cleavage of the nitrogen™sulfur bond with charge
retention on either of the fragment ions, allowing conformation of cross-linked peptides.
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) post source decay
spectra of [M  H] ions of the same sulfinamide-containing cross-linked peptides fragment
similarly, but additional facile fragmentation reactions corresponding to formation of a
protonated peptide containing de-hydroalanine were attributed to cleavage of the
carbon™sulfur bond. In addition, lose of methanesulfenic acid from Met–sulfoxide was
observed. A sulfinamide-containing adduct was isolated after incubation of the A8/HOCl
reaction mixture with Lys or  N-acetyl Lys with masses of 10,500 or 10,542 Da. ESI/MS/MS
and MALDI/ post decay source (PSD) analysis of A832–57–sulfinamide showed the same
characteristic fragmentations as those in the sulfinamide cross-linked peptides, confirming the
Cys41–Lys sulfinamide cross-link and suggesting that peptide–peptide sulfinamides may all
fragment similarly, allowing ready identification of these cross-links in proteins from more
complex biological materials. (J Am Soc Mass Spectrom 2002, 13, 709–718) © 2002 American
Society for Mass Spectrometry
S100 calcium-binding proteins are a family of 18highly conserved, small (10 kDa) acidic proteinswith important regulatory functions including
regulation of kinases, suppression of tumor progres-
sion, embryogenesis, and cell migration [1–5]. S100A8
(A8) has chemotactic activity for leukocytes [6] al-
though other studies indicate additional roles [4, 7],
possibly related to regulating inflammation, when
present at high levels. S100 proteins form non-covalent
homodimers characterized by a symmetric ho-
modimeric fold not found in other Ca2-binding pro-
teins, in solution. Non-covalent A8 homodimers were
also observed using mass spectrometry [8]. Ca2-
binding induces structural changes within helices III
and IV, exposing amino acids within the hinge and
C-terminal domains that may be involved in binding
target proteins [5, 9]. Covalent oxidative modifications
may regulate the functions of S100B, A8, and S100A2
[10–12].
Neutrophils (PMN) release reactive oxygen species
formed via the NADPH oxidase complex following
activation with agents such as phorbol 12-myristate
13-acetate (PMA) and chemoattractants [13]. The respi-
ratory burst produces superoxide anions which dismu-
tate to hydrogen peroxide (H2O2) that is converted by
myeloperoxidase (MPO) and Cl to the powerful two-
electron (non-radical) oxidant hypochlorous acid
(HOCl), which can chemically modify lipids, proteins
and kill invading pathogens [14]. MPO-generated and
exogenous HOCl react identically [15–17] and protein
thiols and Met are preferred substrates [18]. HOCl also
initiates LDL lipid peroxidation and formation of
3-chlorotyrosine and dityrosine [19].
A8 and S100A9 (A9), present constitutively in high
concentrations (40% of cytosolic protein) in PMN,
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may be released from activated or dying cells at inflam-
matory sites [1, 20, 21], making them likely candidates
for oxidation in acute inflammation. High levels of A8
are also released by inflammatory macrophages stimu-
lated by IL-10 [22], suggesting that this protein has an
anti-inflammatory role, possibly by scavenging HOCl.
A8 is effectively oxidized by low amounts of HOCl
(molar ratios of 10) in vitro, with 70–80% conver-
sion to dimer, and neutrophils activated by PMA gen-
erate an oxidative burst that efficiently oxidizes exoge-
nous A8 within 10 min, most likely via H2O2/MPO
released by activated cells [11]. The major A8 HOCl
oxidation products isolated by C4 RP-HPLC corre-
sponded to Cys41–Lys34 and Cys41–Lys35 sulfinamides
containing Met(O) which were formed in 80% yield
[23]. Oxidation of the single Cys in A8 by Cu2 to the
disulfide-linked homodimer was highly specific and
negated its chemotactic properties in vitro and in vivo
[11] whereas the major sulfinamide form remained
active [23]. Positive chemotactic activity of a Cys41 to
Ala41 mutant (Ala41A8) confirmed that Cys41 is not
essential for function, implying that covalent dimeriza-
tion may structurally modify accessibility of the chemo-
tactic hinge domain and may regulate chemotaxis in
vivo. The exquisite susceptibility of A8 to oxidation,
and the potentially large amounts present at sites of
acute inflammation, suggests that it may also have
anti-oxidant properties that protect against excessive
tissue damage.
Here we further describe the oxidation products of
HOCl-oxidised A8 using peptide mapping and mass
spectrometry [23]. Intra-molecular sulfinamide bonds
between Cys41 and 6 of the 7 Lys residues were readily
generated, as well as conversion of Met to Met–sulfox-
ide [Met(O)]. Unusual fragmentations characteristic of
sulfinamides were observed in the low energy CID and
MALDI/PSD spectra of cross-linked peptides. Addi-
tional sulfinamide-containing products, corresponding
to addition of Lys forming an –amino sulfinamide,
were isolated when the amino acid Lys or  N-acetyl
Lys was added the reaction mixture.
Experimental
General
Reagents and chemicals were analytical grade (Sigma,
St. Louis, MO; BioRad, Hercules, CA) and solvents were
HPLC grade (Mallinckrodt, Clayton South, Victoria,
Australia). Hypochlorous acid (10–13%) was from Al-
drich (Milwaukee, WI) and quantitated spectrophoto-
metrically as described [24]. Recombinant A8/Ala41A8
were produced using the pGEX expression system as
detailed [11, 25, 26]. SDS/PAGE/Western blotting were
performed using a Mini Protean II apparatus (BioRad,
Hercules, CA) with 15% gels and a Tris/Tricene buffer
system [27]. Liquid chromatographic separations were
performed using a non-metallic LC626 HPLC system
(Waters, Bedford, MA) and monitored at A214nm and
A280nm with a Waters 996 photodiode array detector or
490 UV/visible detector.
Oxidation Reactions
Oxidation of A8 with hypochlorite. A8 (100 g, 10
nmol) was diluted with PBS (100 l, 25 mM phosphate,
250 mM NaCl, pH 7.5), HOCl (5 l, 50 nmol), and the
solution left at 22 °C for 10 min. Products were sepa-
rated using C4 RP HPLC (5 , 300 Å, 4.6  250 mm,
Vydac, Separations Group, Hesperia, CA) with a gradi-
ent of 35 to 65% CH3CN, 0.1% TFA, over 30 min. Major
peaks (A214nm) were collected and fractions 1 and 1.1
were combined from 10 separate reactions, before par-
tial lyophilization (500 l) and reseparation on HPLC
using a gradient of 25 to 70% CH3CN/0.1% TFA over 30
min, before analysis.
Oxidation of A8 with hypochlorite and reaction with lysine or
N-acetyl Lys. A8 (100 g, 10 nmol) was diluted with
PBS (100 l, 25 mM phosphate, 250 mM NaCl, pH 7.5),
HOCl (5 l, 50 nmol), and the solution left at 22 °C for
20 s, then Lys,  N-acetyl Lys, or  N-acetyl Lys (7.5
l, 340 mM, Aldrich) was added and the solution left
for 10 min at 22 °C. Products were separated using C4
RP HPLC (5 , 300 Å, 4.6 250 mm, Vydac, Separations
Group, Hesperia, CA) with a gradient of 25 to 75%
CH3CN, 0.1% TFA, over 30 min. Major fraction (A214nm)
were collected and lyophilised before MS analysis.
Peptide Mapping
A8 oxidation products (100 g) isolated from C4 RP-
HPLC were digested in ammonium bicarbonate (400 l,
50 mM, pH 8.0) using endoprotease AspN (sequencing
grade, Roche, Castle Hill, NSW) at an enzyme to
substrate ratio of approximately 1:100 at 37 °C for 3 h.
The pH of the digest was adjusted to approximately 2
(TFA 1%) and the mixture applied directly to a C18
RP-column (5 , 300 Å, 4.6  250 mm, Vydac, Separa-
tions Group, Hesperia, CA). Peptides were eluted with
a gradient of 5 to 75% acetonitrile (0.1% TFA) at 1
ml/min over 30 min. Fractions with major A214nm were
collected, then lyophilized and redissolved in H2O/
CH3CN/acetic acid (50:49:1) for ESI or MALDI MS or
further enzymatic digestion.
Both isomers of oxidized A832–57–A862–83 (5 g)
isolated after AspN cleavage were digested with endo-
protease LysC (sequencing grade, Roche) in ammonium
bicarbonate (50 l, 50 mM, pH 8.0) at an enzyme to
substrate ratio of approx. 1:100 at 37 °C for 5 h. Peptides
were isolated using RP-HPLC as described above be-
fore ESI/MALDI MS analysis or the total digest (1 l)
was analyzed by MALDI MS.
Mass Spectrometry
Electrospay ionization mass spectrometry. Masses of pro-
teins and peptides were determined using ESI. Spectra
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were acquired using a single quadrupole mass spec-
trometer equipped with an ESI source (MSD1100,
Hewlett Packard, Palo Alto, CA). Samples (50 pmol,
10 l) were injected into water:acetonitrile (50:50) 1%
acetic acid (10 l/min) using an LC1100 pump (HP)
coupled directly to the electrospray source. Nitrogen
was used as the nebulizer and drying gas (7.0 L/min,
150 °C). Sample droplets were ionized at a positive
potential of approximately 4000 V and transferred to
the mass analyzer with a fragmentor voltage (capillary
to skimmer lens voltage) of 75 V. Spectra were acquired
over the mass range m/z 200 to 1500 in 0.5 s with unit
resolution. Low energy CID MS/MS spectra were re-
corded using a triple quadrupole (TSQ 7000, Finnigan,
San Jose CA) where multiply-charged (3, 4, or 5)
precursor ions were selected with Q1, collisionally
activated within rf-only Q2 (20–50 eV, argon, manifold
pressure 1.5 mTor). Spectra recorded with unit reso-
lution scanning Q3 over m/z 50–2550 in 2 s were
accumulated into a single data file for 4–5 min. Ions
were formed using an in house nano-ESI device. Boro-
silicate glass capillaries (75 1.5 mm) were drawn to an
exit i.d. of 1 m using a micro-pipette puller (Narish-
ige, Model PN-3, Tokyo, Japan) then tips were broken
under a microscope, forming an exit i.d. of 50 m.
Peptide-containing solutions (10 l, H2O/CH3CN/
CH3CO2H, 50:49:1) were loaded into the capillary and
electrical contact (1–2 kV) was maintained using a
gold electrode protruding into the liquid. The glass
capillary was positioned 2–5 mm from the entrance to
the heated capillary, which was at 150 °C; stable ion
currents were maintained with flow rates of 100–200
nl/min.
Matrix assisted laser desorption. Peptide solutions (25
pg/l) were mixed with matrix [1 l, 2,5 dihydroxy-
benzoic acid (DHB, Sigma) 10 mg/ml] and air-dried
before analysis. Spectra were acquired in linear mode
and positive ions generated using a N2 laser (337 nm,
3-ns pulse width) and accelerated to 25 keV after an
extraction delay of 200 s (Voyager STR, Perseptive
Biosystems, Framingham, MA). Typically, 50 spectra
were averaged and calibrated externally using angio-
tensin I and insulin (ox) B chain (peptides) or insulin
(ox) B chain and myoglobin (proteins).
PSD were also acquired using a Voyager STR mass
spectrometer, with the timed ion selector set to the
precursor mass, a mirror ratio of 1.12, 11 segments with
a 75% decrement ratio were acquired and stitched
automatically using the instrument software (Data Ex-
plorer V3.2, Perseptive). In some experiments collision
gas (air) was introduced into a collision cell located
between the source and flight tube to enhance fragmen-
tation. A different target position was chosen for each
segment and 200 spectra acquired and averaged.
Spectra were calibrated using the metastable fragments
of substance P or angiotensin-I (Sigma) and were gen-
erally 1.5 Da of their predicted value for peptides m/z
3000 and 4 for peptides m/z 6000.
Results and Discussion
Hypochlorite (OCl) is the major oxidant produced by
neutrophils in inflammatory responses and murine A8
is exquisitely susceptible to oxidation by HOCl [11, 23].
Low concentrations of hypochlorite (40 M) convert
A8 to a modified monomer (10,354, 46 Da) corre-
sponding to addition of three oxygens and loss of
dihydrogen, and to oxidized dimer (20,707, 93 Da),
indicating oxidation of susceptible amino acids (Cys/
Met) and formation of intra- and inter-molecular sulfi-
namide cross-links [11, 23]. The resistance of Ala41A8 to
HOCl-mediated dimerisation at all HOCl concentra-
tions confirmed the role of Cys41. Reagent or MPO-
generated HOCl form identical reaction products in
proteins [16]. Cys and Met are the preferred substrates
followed by amines (e.g., Lys, forming chloramines) [18,
28]. Almost all  amino acids form reactive aldehydes
after incubation with HOCl formed using the MPO/
H2O2/Cl
 system [24]. Thus, products generated by
reagent HOCl in vitro are likely to reflect those pro-
duced by HOCl generated by activated phagocytes.
Isolation and Characterization of HOCl Oxidation
Products of A8
Murine A8 treated with 4–5 equivalents of HOCl for
10 min at 20 °C yielded 5 separate peaks after C4
RP-HPLC (Figure 1). The major product (Figure 1, peak
3) had a mass of 10,354 1 Da, 46 Da greater than the
unmodified protein. Three additional components of
mass 10,354, 10,354, 10,388, and 10,354/20,707 (Figure 1,
peaks 1, 1.1, 2, and 4) were separated and isolated using
a HPLC gradient of 35 to 65% acetonitrile. We previ-
ously showed that the major product is a mixture of
oxidized Cys41 covalently linked to Lys34/35 via the
–amine forming a sulfinamide bond, and oxidation of
Met to Met(O) [23]. Characterization of the novel sulfi-
namide oxidation product was accomplished using
peptide mapping and mass spectrometry [23]. Other
Figure 1. Preparative C4 RP-HPLC of S100A8 HOCl oxidation
products. (a). Products were separated after incubation of A8 with
5 molar equivalents of HOCl for 10 min at 22 °C. ESI masses
after deconvolution were 10,354 Da (peak 1), 10,354 Da (peak 1.1),
10,388 Da (peak 2, 10,354 Da1 (peak 3), and 10,354/20,707 Da3
(peak 4).
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products identified in the previous study were peak 1
(Cys41–Lys87 sulfinamide) peak 2 (Cys–sulfonic acid),
and peak 4 (Cys41–Lys6 sulfinamide dimer) [23]. Forma-
tion of a reactive Cys–sulfonic acid intermediate that
subsequently underwent nucleophilic substitution by
the –amine (from Lys) was proposed. Early publica-
tions suggest that protein sulfenic acids may undergo
nucleophilic substitution with amines (e.g., ben-
zylamine) to yield stable covalent bonds although none
have been isolated or rigorously characterized [29]. Our
results indicate that seven A8 oxidation products form
after reaction of specific amino acids with a Cys(O)
intermediate and that six of the seven –amines readily
react with this intermediate.
The isomeric HOCl-modified proteins (peaks 1 and
1.1, Figure 1) not fully characterized previously were
digested with AspN and peptides separated by C18
RP-HPLC (Figure 2). The identities of the major digest
peptides were determined based on comparisons of
theoretical and experimental masses. Probable sulfin-
amide-containing peptides had masses of m/z 3802 and
5638. Previously, we showed that the peptide with m/z
3802 contained a sulfinamide between Cys41 and Lys87
[23]. A peptide with an identical experimental and
theoretical mass corresponding to oxidized A832–57
linked to A862–83 (m/z 5638) via a sulfinamide was also
isolated (Figure 2a). This peptide ion may not have been
observed in the previous study because of suppression
of ionization in MALDI [30]. This indicates that peak 1
(Figure 1) is a mixture of A8 oxidation products con-
taining sulfinamides between Cys41–Lys6 and Cys41 and
a Lys within peptide A862–83. The C18 RP-HPLC chro-
matogram of the AspN digest of peak 1.1 shows one
peak with a mass (m/z 5638) also indicating a probable
sulfinamide (Figure 2b). The mass (1 Da) and reten-
tion time (10 s) were identical to the peptide with
sulfinamide between Cys41 and A862–83 isolated after
AspN digestion of peak 1 (Figure 2a and b). C4 RP-
HPLC of peaks 1 and 1.1 revealed that each component
was 95% pure, indicating that there was little cross
contamination of the 2 components and suggesting that
they contain structural isomers. A862–83 has two Lys
residues (Lys76 and Lys83) and the precise identity of the
isomers with m/z 5638 was determined after digestion
of each cross-linked peptide with Lys C.
Endoprotease Lys C cleaves on the C-terminal side of
Lys residues and formation of sulfinamides would
likely inhibit digestion, allowing differentiation of free
and covalently-linked Lys resides. Figure 3 shows the
structures and masses, determined by MALDI and ESI
MS, of isomeric peptides (m/z 5638) digested with LysC
(Figure 3a and b) together with the digest products of
Cys41–Lys6 sulfinamide (Figure 3c) for comparison.
Digestion of sulfinamide oxA832–57–oxA862–83 from
peak 1 gave peptides with masses of m/z 5120 and 408
which correspond to oxA837–57–oxA862–83 and A832–36
indicating that Lys76 was not susceptible to Lys C
digestion and therefore most likely contains the sulfin-
amide bond between Cys41 and Lys76. In comparison,
digestion of sulfinamide oxA832–57–oxA862–83 from
peak 1.1 yielded peptides with masses of m/z 3385, 1770
and 408 which correspond to sulfinamide A837–57–
oxA877–83, oxA862–76 and A832–36 indicating that Lys76
was susceptible to Lys C digestion and therefore the
most likely sulfinamide bond would be between Cys41
and Lys83. The expected Lys C digest products of Cys41–
Lys6 are m/z 3285 and 408 corresponding to sulfinamide
oxA837–57–A82–12 and are identical to the predicted
masses of digestion of this peptide (Figure 3c).
Peak 4 (Figure 1) contains sulfinamide-bonded dimer
of A8, with sulfinamide bonds between Cys41 and Lys6
and Cys41 and Lys34/35 [23]. This peak also contained a
variable proportion of monomer (up to 50%) (mass
10,354 Da) that was not resolved from the dimer using
C4 RP HPLC. A sulfinamide cross-linked peptide
(oxA832–57–A82–12) of mass m/z 4647 was isolated from
peak 4 (Figure 1) after AspN digestion and C18 RP-
HPLC and was also used in the MS structural studies.
The amino acid sequence of A8, together with the
sequence and position of modified Cys and Lys resi-
dues and the structures of the major HOCl oxidation
products of A8, are shown in Figure 4.
Interestingly, sulfinamide bonds in the cross-linked
peptides appeared stable at pH 7 for extended times
(7 days), whereas the bond was hydrolysed within a
few days storage at pH 2.5 (4 °C) forming a peptide
containing Cys–sulfinic acid (CysSO2H) and a peptide
with unmodified Lys. These products were readily sepa-
rated by RP-HPLC and masses determined by ESI (not
shown). A possible hydrolysis mechanism is outlined in
Scheme 1 and is similar to acid-catalysed hydrolysis of
ester/amide bonds [31]. Protein containing sulfinamides
were stable at pH 2 for 6 months at 80 °C.
Figure 2. AspN digestion of S100A8 HOCl oxidation products
[peak 1 and 1.1 (Figure 1)] separated by C18 RP-HPLC. Masses
and predicted identities of digest peptides are indicted for diges-
tion of peak 1 (a) and peak 1.1 (b). Sulfinamide cross-linked
peptides have m/z 3802, 5638 (peak 1), and 5638 (peak 1.1).
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Low Energy Collision Induced Dissociation of
Multiply-Charged Sulfinamide Containing
Peptides
Four sulfinamide cross-linked peptides were analyzed
by ESI low energy CID tandem MS isolated after Asp N
digestion and C18 RP-HPLC of peaks 1, 1.1, and 4.
These corresponded to oxidized A837–57–A884–88 (m/z
3802, Cys41–Lys87 sulfinamide), A837–57–A862–83 (m/z
5638, Cys41–Lys76 sulfinamide), A837–57–A862–83 (m/z
5638, Cys41–Lys83 sulfinamide), and A837–57–A82–12
(m/z 4647, Cys41–Lys6 sulfinamide). The most intense
multiply-charged ion for each peptide was selected
with MS1 and a collision energy chosen that showed the
most intense product ions (Figure 5a, b, c, d). The
collision gas pressure was constant for all MS/MS
spectra at 1.5 mTorr Ar. MS/MS CID spectra of each
multiply-charged ion contained very similar fragmen-
tation patterns for all the sulfinamide cross-linked pep-
tides. Two sets of intense multiply charged product ions
that corresponded to protonated peptides derived after
cleavage of the nitrogen sulfur sulfinamide bond, with
charge retention on either fragment were generally
observed. These products are similar to those expected
after y- or b-type cleavage of peptide bonds after CID
and are designated FN (charge retention on Lys contain-
ing peptide) and FS (charge retention on Cys containing
peptide) fragment ions in Figure 5. FN fragment ions
have experimental masses corresponding to theoretical
masses of protonated peptides containing no modifica-
tions (m/z 0.5). The theoretical average mass of the
[M  H] ion (FS fragments Figure 5) formed after
simple cleavage of the sulfinamide bond was m/z
3187.7. The average experimental mass, derived from
the multiply charged fragment ions, is m/z 3188
(0.6). Charge remote fragmentation mechanism
have been proposed for elimination reactions of pro-
tonated peptides containing alkylated oxidized Cys
resides after low energy CID with a Q-star mass
spectrometer [32]. More accurate products ion mass
measurement using a Q-TOF or MS3 (ion trap) may
resolve the precise mechanism and the products
formed during low energy CID of sulfinamide
bonded peptides. Additional ions, some correspond-
ing to the expected sequence ions of both peptides
were also observed and were enhanced by increasing
the collision energy by 50 –100% (not shown).
MALDI-Post Source Decay Analysis of Protonated
Sulfinamide Containing Peptides
The four sulfinamide cross-linked peptides from C18
RP-HPLC were analyzed by MALDI/PSD using DHB
Figure 3. Products of endoprotease Lys C digestion of sulfinamide cross-linked peptides m/z 5638
and 3802. The specific Lys residues on isomeric peptides (m/z 5638) derived from AspN digestion of
peaks 1 (a) and 1.1 (b) were determined after digestion with endoprotease LysC because sulfinamide-
linked Lys resides were resistant to protease digestion.
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matrix (Figure 6a, b, c, d) after selecting the precursor
ion using the timed ion selector. Apart from an increase
in the intensities of low-mass immonium ions, identical
spectra were obtained employing CID (not shown).
Mass accuracy of product ions were generally within
m/z 1.5 of theoretical values for precursor ions at
3000 and m/z 4 for precursor ions at 6000.
Although product ion mass accuracy was modest, frag-
mentations of sulfinamides, which were only evident
by MALDI, were observed and are probably high-
energy or photo-dissociation processes not normally
observed in low energy CID MS/MS spectra using
triple quadrupoles. Fragmentation of the sulfinamide
bond forming two protonated product ions, similar to
those observed in the ESI/MS/MS spectra, were also
evident in the PDS spectra (i.e., ions at m/z 3190 in
Figure 6a, b, c, d and 2449 in b and c). However
additional fragmentations characteristic of sulfinamides
and Met(O) that corresponded to elimination reactions
forming dehydro-alanine were also observed. Elimina-
tions of this type in CID MS/MS spectra were recently
reported for alkylated oxidized Cys residues [32] and
Met(O) readily eliminates methanesulfenic acid [33].
Scheme 2 proposes a similar charge remote fragmenta-
tion mechanism to account for the formation of a
protonated peptide containing dehydro-alanine after
CID of protonated sulfinamides. Loss of m/z 64 from
the precursor ion, and from other major ions, corre-
sponds to the loss of methansulfenic acid from Met(O)
would occur as described [32, 33]. More accurate prod-
uct ion mass measure, possibly using high energy CID
with a TOF-TOF MS, would allow products ions and
fragmentation mechanism to be more precisely defined
[34]. The ion at m/z 1974 in all PSD spectra corresponds
to the sequence A842–57 (PQFVQNINIENLFREL) formed
after y-type peptide bond cleavage of the Cys41–Pro42
bond of the precursor ion.
Low Energy CID/MALDI PSD Analysis of
A8–Lys Sulfinamide Adduct
The reactivity of the initially-formed A8–Cys sulfenic
acid was tested by addition of lysine,  N-acetyl lysine
or  N-acetyl lysine to the reaction mixture. The C4
RP-HPLC chromatograms were virtually unchanged
except for a minor peak eluting as a partially resolved
shoulder before peak 2 (Figure 1) after addition of Lys,
which was isolated (not shown). The mass of this
adduct was 10,500 Da and corresponds to the theoreti-
cal mass (10,499.5 Da) of Met-oxidized A8 covalently
linked to Lys via a sulfinamide bond. No additional
adducts were isolated after addition of  N-acetyl Lys,
but an adduct with 10542 Da was isolated after incuba-
tion with  N-acetyl Lys, corresponding to -substi-
tuted A8  N-acetyl Lys sulfinamide (theoretical mass
10542 Da), indicating preferential substitution of the
–amine versus –amine of Lys. The most likely protein
containing sulfinamides would also be via the –amine
of Lys.
Digestion of the A8–Lys sulfinamide adduct with
AspN and separation by C18 RP-HPLC revealed the
expected A8 digest peptides together with a peptide
corresponding to A832–57–Lys sulfinamide (m/z 3336)
(not shown). Fragmentations consistent with a Cys41–
Lys sulfinamide were identified using ESI low energy
CID MS/MS and MALDI PSD analysis of isolated
peptides. Electrospray low energy CID MS/MS spectra
of [M  4H]4 and [M  3H]3 precursor ions of
A832–57–Lys sulfinamide are shown in Figure 7a and b.
Similar to the fragmentations observed in the spectra of
the sulfinamide cross-linked peptides (Figure 5), the
major fragmentation in both spectra is cleavage of the
sulfinamide bond forming protonted Lys (m/z 147) and
Figure 4. Structures of sulfinamide cross-linked S100A8. (a) A8
amino acid sequence indicating locations of Lys, Met, and Cys
residues modified by HOCl oxidation (labeled with a pound sign
or an asterisk). Six of the seven Lys resides in S100A8 formed
sulfinamide cross-links with the reactive intermediate Cys41
sulfenic acid. (b) Proposed structures of Cys41–LysX sulfinamide-
bonded products identified after oxidation of A8 with HOCl. The
structures of the major products (peaks 2, 3, and 4) were deter-
mined in a previous study [23].
Scheme 1 Acid catalysed hydrolysis of sulfinamide cross-linked
peptides forms Cys–sulfinic acid and Lys containing peptides.
714 RAFTERY AND GECZY J Am Soc Mass Spectrom 2002, 13, 709–718
Figure 5. Low energy CID MS/MS spectra of protonated sulfinamide containing peptides. Colli-
sional activation of multiply-charged sulfinamide cross-linked peptides caused simple cleavage of the
nitrogen™sulfur bond forming two peptide fragments which share the charges originally located on
the precursor ion. Precursor ions are indicated together with major fragment ions, these are designated
FN or FS and charge states are shown in parenthesis (the insert in each spectrum shows the structure
of precursor ion and experimentally derived m/z of singly protonated precursor and product ions). (a)
[M  4H]4 ion (m/z 951.4) of A832–57–A884–88 (Cys41–Lys87 sulfinamide) was fragmented at 25 eV,
forming major product ions at m/z 1063.4 and 615.4; similarly, (b) [M  5H]5 ion (m/z 1128.2) of
A832–57–oxA862–83 (Cys41–Lys83 sulfinamide) was fragmented at 40 eV, forming major product ions at
m/z 1595.2, 1063.4, 1225.9, and 817.6; (c) [M 4H]4 ion (m/z 1410.2) of A832–57–oxA862–83 (Lys76–Cys41
sulfinamide) was fragmented at 50 eV, forming major product ions at m/z 1594.5 and 1225.0; and (d)
[M  4H]4 ion (m/z 1162.3) of A82–12–A832–57 (Cys41–Lys6 sulfinamide) was fragmented at 50 eV,
forming major product ions at m/z 1063.5 and 1458.4.
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a protonated peptide with m/z 3188. Some additional
ions corresponding to peptide bond cleavages of pro-
tonated oxA832–57 are also evident at higher collision
energies (not shown). Fragmentations in the MALDI
PSD spectra were also consistent with A832–57–Lys
sulfinamide (Figure 7c). Major losses forming proton-
ated dehydroalanine41–oxA832–57 (m/z 3139) with sub-
sequent loss of methanesulfenic acid (m/z 3077.4) were
the most intense peaks observed. Loss of methane-
sulfenic acid from the precursor the ion at m/z 3273.1
was evident. Peptide bond fragmentations (y-type) are
also shown; y17–19,21 indicate the presence of dehy-
droalanine, suggesting that formation of this product
ion is very favorable in MALDI (high energy) processes.
Conclusions
Sulfinamide bond formation is a novel oxidative cross-
linking process resulting in covalent bonds between
thiols and amines, which may stabilise/modify protein
function and would be resistant to regeneration by
conventional pathways involving reductases. In the
inflammatory milieu, sulfinamide bond formation be-
tween Lys and Cys residues in proteins, or S100 cross-
linking with other proteins, could potentially regulate
normal and pathological processes. HOCl generated by
activated macrophages in inflammatory lesions modi-
fies Apo B 100 in LDL without significant lipid oxida-
tion. Apo B becomes aggregated and cross-linked, with
loss of amines producing a high uptake form that
accelerates foam cell formation in atherosclerosis [16].
The protein may be cross-linked/aggregated by sulfin-
amide bonds. Further experiments are required to de-
fine the generality of this oxidative modification and its
importance in regulating protein function and disease
processes, particularly relevant to aging, atherogenesis,
fibrosis, and neurogenerative diseases. The sensitivity
and specificity of mass spectrometry will allow charac-
terization of sulfinamides isolated from inflammatory
lesions, or from normal tissue, where they may form
only at low levels.
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